☆ 4.7 Letter

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

ANNALS OF THE RHEUMATIC DISEASES (2020)

期刊

ANNALS OF THE RHEUMATIC DISEASES

卷 79, 期 10, 页码 1386-1388

出版社

BMJ PUBLISHING GROUP

DOI: 10.1136/annrheumdis-2020-217690

关键词

lupus erythematosus; systemic; hydroxychloroquine; epidemiology; pharmacokinetics

类别

Rheumatology

资金

National Institute for Health Research University College London Hospitals Biomedical Research Centre

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Chemistry, Medicinal

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus

Noel Zahr, Saik Urien, Christian Funck-Brentano, Helene Vantomme, Nicolas Garcelon, Isabelle Melki, Margaux Boistault, Olivia Boyer, Brigitte Bader-Meunier

Summary: This study investigated the pharmacokinetics of hydroxychloroquine (HCQ) in pediatric patients with systemic lupus erythematosus (SLE). The results showed that HCQ blood concentration was associated with disease activity and could serve as a significant predictor of disease status.

PHARMACEUTICALS (2021)

添加到收藏夹

Article Medicine, General & Internal

Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark

Rene Cordtz, Salome Kristensen, Louise Plank Holm Dalgaard, Rasmus Westermann, Kirsten Duch, Jesper Lindhardsen, Christian Torp-Pedersen, Lene Dreyer

Summary: Patients with systemic lupus erythematosus (SLE) have a higher risk of hospitalisation with COVID-19 infection, and the use of hydroxychloroquine treatment may reduce the risk of hospitalisation.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Review Medicine, General & Internal

Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies

Xian-Bao Li, Nv-Wei Cao, Xiu-Jie Chu, Hao-Yue Zhou, Hua Wang, Si-Jie Yu, Dong-Qing Ye, Bao-Zhu Li

Summary: Antimalarials, especially hydroxychloroquine, may reduce the risk of cancer in patients with systemic lupus erythematosus (SLE), with significant risk reduction seen in Asian populations and SLE patients from multiple centers.

ANNALS OF MEDICINE (2021)

添加到收藏夹

Article Rheumatology

Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine

Celline C. Almeida-Brasil, John G. Hanly, Murray Urowitz, Ann Elaine Clarke, Guillermo Ruiz-Irastorza, Caroline Gordon, Rosalind Ramsey-Goldman, Michelle A. Petri, Ellen M. Ginzler, Daniel J. Wallace, Sang-Cheol Bae, Juanita Romero-Diaz, Mary-Anne Dooley, Christine Peschken, David Isenberg, Anisur Rahman, Susan Manzi, Soren Jacobsen, S. Sam Lim, Ronald van Vollenhoven, Ola Nived, Andreas Joensen, Diane L. Kamen, Cynthia Aranow, Jorge Sanchez-Guerrero, Dafna D. Gladman, Paul R. Fortin, Graciela S. Alarcon, Joan T. Merrill, Kenneth Kalunian, Manuel Ramos-Casals, Kristjan Steinsson, A. Zoma, Anca D. Askanase, Munther Khamashta, Ian N. Bruce, Murat Inanc, Luck Lukusa, Sasha Bernatsky

Summary: This study evaluates hydroxychloroquine (HCQ)-related retinal toxicity in patients with newly diagnosed systemic lupus erythematosus (SLE). The study found no cases of retinopathy within the first four years of HCQ use. Cumulative HCQ use may be associated with an increased risk of retinal toxicity. Therefore, ophthalmology monitoring remains important, especially in patients using HCQ for a long duration, requiring higher doses, and diagnosed with SLE at an older age.

LUPUS SCIENCE & MEDICINE (2022)

添加到收藏夹

Article Immunology

Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry

Chiharu Hidekawa, Ryusuke Yoshimi, Yusuke Saigusa, Jun Tamura, Noriko Kojitani, Naoki Suzuki, Natsuki Sakurai, Yuji Yoshioka, Yumiko Sugiyama-Kawahara, Yosuke Kunishita, Daiga Kishimoto, Kana Higashitani, Yuichiro Sato, Takaaki Komiya, Hideto Nagai, Naoki Hamada, Ayaka Maeda, Naomi Tsuchida, Lisa Hirahara, Yutaro Soejima, Kaoru Takase-Minegishi, Yohei Kirino, Nobuyuki Yajima, Ken-ei Sada, Yoshia Miyawaki, Kunihiro Ichinose, Shigeru Ohno, Hiroshi Kajiyama, Shuzo Sato, Yasuhiro Shimojima, Michio Fujiwara, Hideaki Nakajima

Summary: Hydroxychloroquine may help extend the time until the occurrence of infection complications in patients with systemic lupus erythematosus and tends to decrease infection rates.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Association between cumulative dose of hydroxychloroquine and electrocardiographic abnormalities in patients with systemic lupus erythematosus

Jon Zubiaur, Alba Herrero-Morant, Adrian Margarida de Castro, Raquel Perez-Barquin, Ivan Ferraz-Amaro, Javier Loricera, Santos Castaneda, Ricardo Blanco

Summary: This retrospective observational study examined the association between cumulative hydroxychloroquine (HCQ) dose and electrocardiographic (EKG) abnormalities in patients with systemic lupus erythematosus (SLE). The results showed that higher cumulative HCQ dose was associated with conduction disturbances, but this association disappeared after multivariate adjustment. There was no significant increase in the development of structural abnormalities.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

添加到收藏夹

Article Rheumatology

Multimorbidity in systemic lupus erythematosus in a population-based cohort: the Lupus Midwest Network

Gabriel Figueroa-Parra, Jose A. Meade-Aguilar, Cassondra A. Hulshizer, Tina M. Gunderson, Alanna M. Chamberlain, Uma Thanarajasingam, Kurt J. Greenlund, Kamil E. Barbour, Cynthia S. Crowson, Ali Duarte-Garcia

Summary: The study aimed to assess the prevalence and incidence of multimorbidity and its association with the SLICC/ACR damage index (SDI) among patients with SLE. The results showed that patients with SLE were more likely to have multimorbidity, both before and after the onset of the disease. Multimorbidity was driven by both SDI-related and unrelated conditions.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Pharmacokinetics of hydroxychloroquine in Japanese systemic lupus erythematosus patients with renal impairment

Mikiko Shimizu, Sumito Furudate, Yoshiki Nagai, Kota Shimada, Miho Ohshima, Keigo Setoguchi, Masayuki Hashiguchi, Naoto Yokogawa

Summary: This study found that a dosage reduction of hydroxychloroquine is unnecessary in SLE patients with impaired renal function based on pharmacokinetic analysis.

MODERN RHEUMATOLOGY (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients

Jose F. Polanski, Eloise A. Tanaka, Harymy Barros, Adriana G. Chuchene, Patricia T. G. Miguel, Thelma L. Skare

Summary: SLE patients have a higher prevalence of sensorineural hearing loss, unaffected by the use of antimalarial drugs. Pure-tone averages are similar between users and non-users of antimalarials, but non-users perform worse at 8000Hz. Serological and clinical profiles in SLE patients with and without hearing loss are similar.

LARYNGOSCOPE (2021)

添加到收藏夹

Article Rheumatology

Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study

Jingru Tian, Dingyao Zhang, Xu Yao, Yaqing Huang, Qianjin Lu

Summary: This study estimated the epidemiology of SLE globally, finding variations in incidence and prevalence rates across different countries and regions. It also highlighted the impact of gender, age, and prevalence estimation method on the findings. SLE was found to occur more frequently in high-income countries.

ANNALS OF THE RHEUMATIC DISEASES (2023)

添加到收藏夹

Article Rheumatology

Hydroxychloroquine and immunosuppressant adherence patterns and their association with subsequent hospitalization rates among children with systemic lupus erythematosus

Joyce C. Chang, Karen H. Costenbader

Summary: By studying children with systemic lupus erythematosus (SLE) in the United States, this research examined the adherence to hydroxychloroquine and immunosuppressant medications. It found that assessing immunosuppressant adherence concurrently adds value to hydroxychloroquine adherence assessments and that prescription claims-based immunosuppressant adherence measures are predictive of acute care utilization.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2022)

添加到收藏夹

Article Rheumatology

Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus

Xianyong Yin, Kwangwoo Kim, Hiroyuki Suetsugu, So-Young Bang, Leilei Wen, Masaru Koido, Eunji Ha, Lu Liu, Yuma Sakamoto, Sungsin Jo, Rui-Xue Leng, Nao Otomo, Viktoryia Laurynenka, Young-Chang Kwon, Yujun Sheng, Nobuhiko Sugano, Mi Yeong Hwang, Weiran Li, Masaya Mukai, Kyungheon Yoon, Minglong Cai, Kazuyoshi Ishigaki, Won Tae Chung, He Huang, Daisuke Takahashi, Shin-Seok Lee, Mengwei Wang, Kohei Karino, Seung-Cheol Shim, Xiaodong Zheng, Tomoya Miyamura, Young Mo Kang, Dongqing Ye, Junichi Nakamura, Chang-Hee Suh, Yuanjia Tang, Goro Motomura, Yong-Beom Park, Huihua Ding, Takeshi Kuroda, Jung-Yoon Choe, Chengxu Li, Hiroaki Niiro, Youngho Park, Changbing Shen, Takeshi Miyamoto, Ga-Young Ahn, Wenmin Fei, Tsutomu Takeuchi, Jung-Min Shin, Keke Li, Yasushi Kawaguchi, Yeon-Kyung Lee, Yongfei Wang, Koichi Amano, Dae Jin Park, Wanling Yang, Yoshifumi Tada, Ken Yamaji, Masato Shimizu, Takashi Atsumi, Akari Suzuki, Takayuki Sumida, Yukinori Okada, Koichi Matsuda, Keitaro Matsuo, Yuta Kochi, Leah C. Kottyan, Matthew T. Weirauch, Sreeja Parameswaran, Shruti Eswar, Hanan Salim, Xiaoting Chen, Kazuhiko Yamamoto, John B. Harley, Koichiro Ohmura, Tae-Hwan Kim, Sen Yang, Takuaki Yamamoto, Bong-Jo Kim, Nan Shen, Shiro Ikegawa, Hye-Soon Lee, Xuejun Zhang, Chikashi Terao, Yong Cui, Sang-Cheol Bae

Summary: This study conducted the largest genome-wide meta-analysis for SLE in East Asian populations, identifying 46 novel loci and prioritizing putative causal variants using Bayesian statistical approach. The findings highlight the power of large-scale genetic discovery in shedding light on the genetic and biological understandings of SLE.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Article Rheumatology

Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

Manuel Francisco Ugarte-Gil, John Hanly, Murray Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Ann Elaine Clarke, Daniel J. Wallace, David Alan Isenberg, Anisur Rahman, Joan T. Merrill, Paul R. Fortin, Dafna D. Gladman, Ian N. Bruce, Michelle Petri, Ellen M. Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jonsen, Ronald F. van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanc, Ken Kalunian, Soren Jacobsen, Christine Peschken, Diane L. Kamen, Anca Askanase, Bernardo A. Pons-Estel, Graciela S. Alarcon

Summary: This study investigated the impact of different definitions of remission and low disease activity on damage accrual in patients with lupus. The results show that both remission on-treatment and off-treatment, as well as low disease activity and modified lupus low disease activity, are associated with less damage accrual.

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Article Medicine, General & Internal

Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus A case report

Gang Wang, Ning Zhuo, Zheng Liao, Wei Qi, Feng Tian, Zhenhua Wen, Jingyang Li

Summary: Hydroxychloroquine has excellent anti-inflammatory and immunomodulatory effects, but the risk of retinopathy should be taken seriously. To prevent retinopathy, discontinuation of hydroxychloroquine, better eye protection, and regular vision checks are essential.

MEDICINE (2021)

添加到收藏夹

Article Rheumatology

Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls

Irene E. M. Bultink, Frank de Vries, Ronald F. van Vollenhoven, Arief Lalmohamed

Summary: Patients with SLE in the UK have a 1.8-fold increased mortality rate compared to the general population, with the highest risk for those aged 18-39 years old; low-dose HCQ reduces the risk of mortality by 45%.

RHEUMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Depressed Symptomatology in Systemic Lupus Erythematosus Patients

Sara R. R. Kellahan, Xinliang Huang, Daphne Lew, Hong Xian, Seth Eisen, Alfred H. J. Kim

Summary: This study examined the longitudinal course of depressed affect among outpatients with systemic lupus erythematosus (SLE) and the relationship between SLE disease activity and depressed affect. The majority of patients had persistent depressed affect or major depression over a period of up to 4 years, and there was no consistent relationship between depressed affect and SLE disease activity.

ARTHRITIS CARE & RESEARCH (2023)

添加到收藏夹

Article Microbiology

Impact of Vancomycin Loading Doses and Dose Escalation on Glomerular Function and Kidney Injury Biomarkers in a Translational Rat Model

Jack Chang, Gwendolyn M. Pais, Patti L. Engel, Patryk Klimek, Sylwia Marianski, Kimberly Valdez, Marc H. Scheetz

Summary: Vancomycin-induced kidney injury is common, and outcomes in humans are well predicted by animal models. This study employed our translational rat model to investigate temporal changes in the glomerular filtration rate (GFR) and correlations with kidney injury biomarkers related to various vancomycin dosing strategies.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

添加到收藏夹

Correction Pharmacology & Pharmacy

Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial (Oct, 10.1007/s40261-022-01204-z, 2022)

Amy Legg, Niamh Meagher, Sandra A. Johnson, Matthew A. Roberts, Alan Cass, Marc H. Scheetz, Jane Davies, Jason A. Roberts, Joshua S. Davis, Steven Y. C. Tong

CLINICAL DRUG INVESTIGATION (2023)

添加到收藏夹

Letter Immunology

Nephrotoxin Stewardship Alongside Antimicrobial Stewardship

Marc H. Scheetz, Jack Chang, Erin F. Barreto, Anand Srivastava, Kimberly Valdez, Sylwia Marianski, Gwendolyn M. Pais, Todd Miano

CLINICAL INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Medicine, General & Internal

Outcomes of COVID-19 in people with rheumatic and musculoskeletal disease in Ireland over the first 2 years of the pandemic

Richard Conway, Elena Nikiphorou, Christiana A. Demetriou, Candice Low, Kelly Leamy, John G. Ryan, Ronan Kavanagh, Alexander D. Fraser, John J. Carey, Paul O'Connell, Rachael M. Flood, Ronan H. Mullan, David J. Kane, Frances Stafford, Philip C. Robinson, Jean W. Liew, Rebecca Grainger, Geraldine M. McCarthy

Summary: This study investigated the COVID-19 outcomes for individuals with rheumatic and musculoskeletal diseases in Ireland. The results showed that increasing age, gout, smoking, long-term glucocorticoid use, comorbidities, and specific comorbidities were associated with higher rates of hospitalization and mortality.

IRISH JOURNAL OF MEDICAL SCIENCE (2023)

添加到收藏夹

Article Rheumatology

Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19 A Multicenter Retrospective Cohort Study

Kanon Jatuworapruk, Panchalee Satpanich, Philip C. Robinson, Rebecca Grainger

Summary: This study aimed to investigate the prevalence and outcomes of gout flare in COVID-19 hospitalized patients with comorbid gout. It was found that gout flare occurred in 18% of the hospitalized patients and added up to 3 days to the hospital length of stay.

JOURNAL OF RHEUMATOLOGY (2023)

添加到收藏夹

Review Rheumatology

The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for Therapeutics

Anuja Java, Alfred H. J. Kim

Summary: The complement system is a crucial component connecting the innate and humoral immune systems, but it can also be damaging to host tissue if misdirected or dysregulated. It plays an important role in atypical hemolytic uremic syndrome (aHUS), a thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ injury. However, the role of complement in TMA associated with other diseases and its interaction with neutrophils and coagulation pathways complicates the understanding of its involvement. Understanding the role of complement in TMA associated with autoimmune diseases will help in timely diagnosis and management.

JOURNAL OF RHEUMATOLOGY (2023)

添加到收藏夹

Article Pediatrics

Urine biomarker score captures response to induction therapy with lupus nephritis

Ellen M. Cody, Scott E. Wenderfer, Kathleen E. Sullivan, Alfred H. J. Kim, Wesley Figg, Harneet Ghumman, Tingting Qiu, Bin Huang, Prasad Devarajan, Hermine Brunner

Summary: The Renal Activity Index for Lupus (RAIL) can non-invasively identify lupus nephritis (LN) and assess the efficacy of LN induction therapy. RAIL scores can differentiate clinically active LN from inactive LN or without LN. RAIL scores significantly decrease after complete LN remission.

PEDIATRIC NEPHROLOGY (2023)

添加到收藏夹

Article Rheumatology

Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution

Tim McEwan, Jaspreet Bhambra, David F. Liew, Philip C. Robinson

Summary: This study aimed to identify reports of colchicine-induced neuropathy and myopathy and determine the risk factors associated with this toxicity at commonly used doses. A systematic review of case reports found 143 cases of neuromyopathy associated with the use of colchicine. Most cases presented with features of both neuropathy and myopathy, with symptoms of myopathy being predominant. Cessation of colchicine generally led to complete resolution of symptoms.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2023)

添加到收藏夹

Article Rheumatology

Impact of the COVID-19 Pandemic on Early Career Investigators in Rheumatology: Recommendations to Address Challenges to Early Research Careers

Kristine A. Kuhn, Andrew Stahly, Maximilian F. Konig, Kristine Carandang, Connie Herndon, Catherine Backman, Leigh F. Callahan, Grant Schulert, Liana Fraenkel, Alexis Ogdie

Summary: This study assessed the impact of the COVID-19 pandemic on trainees and early career investigators and proposed ways for the ACR and RRF to address their needs. The survey revealed that 75% of respondents pursuing academic research careers had to put their primary projects on hold during the pandemic. The suggested interventions included increased funding, funding process reform, and expanding mentoring and networking resources.

ARTHRITIS CARE & RESEARCH (2023)

添加到收藏夹

Article Biochemical Research Methods

Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-Seq

Roger S. Zou, Yang Liu, Oscar E. Reyes Gaido, Maximilian F. Konig, Brian J. Mog, Leo L. Shen, Franklin Aviles-Vazquez, Alberto Marin-Gonzalez, Taekjip Ha

Summary: DISCOVER-Seq+ is a highly sensitive method that detects off-target effects of CRISPR genome editing. By inhibiting DNA-dependent protein kinase catalytic subunit and accumulating the repair protein MRE11 at CRISPR-Cas-targeted sites, off-target sites can be mapped to positions of MRE11 binding using chromatin immunoprecipitation followed by sequencing. This technique, DISCOVER-Seq+, has discovered up to fivefold more off-target sites compared to previous methods in various cell lines and animal models.

NATURE METHODS (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT)

William Taylor, Robin Willink, Denise A. O'Connor, Vinay L. Patel, Allison Bourne, Ian Harris, Samuel Whittle, Bethan S. Richards, Ornella G. Clavisi, Sally Green, Rana Hinman, Chris Maher, Ainslie E. Cahill, Annie McPherson, Charlotte C. Hewson, Suzie May, Bruce Walker, Philip Robinson, Davina Ghersi, Jane Fitzpatrick, Tania Winzenberg, Kieran Fallon, Paul Glasziou, Laurent Billot, Rachelle Buchbinder

Summary: The Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network developed a Research Question Importance Tool (ANZMUSC-RQIT) to rank research projects based on their importance. The tool consists of 5 dimensions and is designed for scoring by committee consensus.

PLOS ONE (2023)

添加到收藏夹

Article Infectious Diseases

Nickel ion-anchored helical braided binder network with soft-rigid synergy and self-recovery ability for high-performance silicon anode

Sarah E. Greene, Yuefang Huang, Wooseob Kim, Mariel J. Liebeskind, Vinay Chandrasekaran, Zhuoming Liu, Parakkal Deepak, Michael A. Paley, Daphne Lew, Monica Yang, Mehrdad Matloubian, Lianne S. Gensler, Mary C. Nakamura, Jane A. O'Hallaran, Rachel M. Presti, Sean P. J. Whelan, William J. Buchser, Alfred H. J. Kim, Gary J. Weil

Summary: This study tested samples from immunocompetent adults and those receiving treatments for chronic inflammatory diseases before and after mRNA SARS-CoV-2 vaccination. The lateral flow assay (LFA) detected anti-S antibodies in the majority of participants and showed significant correlation with ELISA results. LFA could be a practical alternative for detecting antibodies after infection or vaccination, particularly in outpatient or resource-limited settings.

JOURNAL OF CLINICAL VIROLOGY PLUS (2023)

添加到收藏夹

Article Infectious Diseases

Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults

Jack Chang, Jiajun Liu, Mohammad H. Alshaer, Veena Venugopalan, Nicole Maranchick, Charles A. Peloquin, Nathaniel J. Rhodes, Marc H. Scheetz

Summary: A study was conducted to investigate the variability in cefepime exposures among real-world ICU patients using modeling and simulations. The results showed wide variations in cefepime exposure among patients with similar kidney function estimates. Current population adjustment schemes based solely on creatinine clearance may result in unintended high and low drug exposures, raising concerns about safety and efficacy.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

添加到收藏夹

Article Rheumatology

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

Pedro M. Machado, Martin Schaefer, Satveer K. Mahil, Jean Liew, Laure Gossec, Nick Dand, Alexander Pfeil, Anja Strangfeld, Anne Constanze Regierer, Bruno Fautrel, Carla Gimena Alonso, Carla G. S. Saad, Christopher E. M. Griffiths, Claudia Lomater, Corinne Miceli-Richard, Daniel Wendling, Deshire Alpizar Rodriguez, Dieter Wiek, Elsa F. Mateus, Emily Sirotich, Enrique R. Soriano, Francinne Machado Ribeiro, Felipe Omura, Frederico Rajao Martins, Helena Santos, Jonathan Dau, Jonathan N. Barker, Jonathan Hausmann, Kimme L. Hyrich, Lianne Gensler, Ligia Silva, Lindsay Jacobsohn, Loreto Carmona, Marcelo M. Pinheiro, Marcos David Zelaya, Maria de los Angeles Severina, Mark Yates, Maureen Dubreuil, Monique Gore-Massy, Nicoletta Romeo, Nigil Haroon, Paul Sufka, Rebecca Grainger, Rebecca Hasseli, Saskia Lawson-Tovey, Suleman Bhana, Thao Pham, Tor Olofsson, Wilson Bautista-Molano, Zachary S. Wallace, Zenas Z. N. Yiu, Jinoos Yazdany, Philip C. Robinson, Catherine H. Smith

Summary: This study investigated factors associated with severe COVID-19 in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis. The study found that age, sex, comorbidities, disease activity, and glucocorticoid use were associated with the severity of COVID-19. Additionally, later pandemic time periods, psoriasis, and the use of TNFi, IL17i, and IL-23i/IL-12+23i were associated with a reduced risk of severe COVID-19.

ANNALS OF THE RHEUMATIC DISEASES (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.